Invention Application
- Patent Title: PHOSPHOLIPASE INHIBITORS LOCALIZED IN THE GASTROINTESTINAL LUMEN
- Patent Title (中): 位于胃肠道内的磷脂酶抑制剂
-
Application No.: PCT/US2005/015418Application Date: 2005-05-03
-
Publication No.: WO2005107766A1Publication Date: 2005-11-17
- Inventor: CHARMOT, Dominique , BUYSSE, Jerry, M. , CHANG, Han, Ting , COPE, Michael, James , HUI, David
- Applicant: ILYPSA, INC. , CHARMOT, Dominique , BUYSSE, Jerry, M. , CHANG, Han, Ting , COPE, Michael, James , HUI, David
- Applicant Address: 3410 Central Expressway, Santa Clara, CA 95051 US
- Assignee: ILYPSA, INC.,CHARMOT, Dominique,BUYSSE, Jerry, M.,CHANG, Han, Ting,COPE, Michael, James,HUI, David
- Current Assignee: ILYPSA, INC.,CHARMOT, Dominique,BUYSSE, Jerry, M.,CHANG, Han, Ting,COPE, Michael, James,HUI, David
- Current Assignee Address: 3410 Central Expressway, Santa Clara, CA 95051 US
- Agency: STONE, Paul, A.
- Priority: US10/838,879 20040503
- Main IPC: A61K31/66
- IPC: A61K31/66
Abstract:
The present invention provides methods and compositions for the treatment of phospholipase-related conditions. In particular, the invention provides a method of treating insulin-related, weight-related conditions and/or cholesterol-related conditions in an animal subject. The method generally involves the administration of a non-absorbed and/or effluxed phospholipase A2 inhibitor that is localized in a gastrointestinal lumen.
Information query
